You are here:

mesalazine 1200mg gastro-resistant prolonged release tablet (Mezavant XL)

Advice

Following an abbreviated submission

mesalazine 1200mg gastro-resistant prolonged release tablet (Mezavant XL®) is accepted for use within NHS Scotland for the induction of clinical and endoscopic remission in patients with mild to moderate, active ulcerative colitis, and for maintenance of remission.

It may be used in cases where mesalazine is an appropriate choice of treatment and offers the possible advantage of once-daily administration.

Drug Details

Drug Name: mesalazine 1200mg gastro-resistant prolonged release tablet (Mezavant XL)
SMC Drug ID: 445/08
Manufacturer: Shire Pharmaceuticals
Indication: for the induction of clinical and endoscopic remission in patients with mild to moderate active ulcerative colitis, and for maintenance remission
BNF Category:
Sub Category: 1.5 Chronic bowel disorders
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 10 March 2008

Back